Camus, B.; Cottereau, A.-S.; Palmieri, L.-J.; Dermine, S.; Tenenbaum, F.; Brezault, C.; Coriat, R.
Indications of Peptide Receptor Radionuclide Therapy (PRRT) in Gastroenteropancreatic and Pulmonary Neuroendocrine Tumors: An Updated Review. J. Clin. Med. 2021, 10, 1267.
https://doi.org/10.3390/jcm10061267
AMA Style
Camus B, Cottereau A-S, Palmieri L-J, Dermine S, Tenenbaum F, Brezault C, Coriat R.
Indications of Peptide Receptor Radionuclide Therapy (PRRT) in Gastroenteropancreatic and Pulmonary Neuroendocrine Tumors: An Updated Review. Journal of Clinical Medicine. 2021; 10(6):1267.
https://doi.org/10.3390/jcm10061267
Chicago/Turabian Style
Camus, Baptiste, Anne-Ségolène Cottereau, Lola-Jade Palmieri, Solène Dermine, Florence Tenenbaum, Catherine Brezault, and Romain Coriat.
2021. "Indications of Peptide Receptor Radionuclide Therapy (PRRT) in Gastroenteropancreatic and Pulmonary Neuroendocrine Tumors: An Updated Review" Journal of Clinical Medicine 10, no. 6: 1267.
https://doi.org/10.3390/jcm10061267
APA Style
Camus, B., Cottereau, A.-S., Palmieri, L.-J., Dermine, S., Tenenbaum, F., Brezault, C., & Coriat, R.
(2021). Indications of Peptide Receptor Radionuclide Therapy (PRRT) in Gastroenteropancreatic and Pulmonary Neuroendocrine Tumors: An Updated Review. Journal of Clinical Medicine, 10(6), 1267.
https://doi.org/10.3390/jcm10061267